VCU researchers demonstrate safety and effectiveness of fecal transplantation on brain function
Virginia Commonwealth University News Jun 21, 2017
Researchers at Virginia Commonwealth University School of Medicine have successfully demonstrated that transferring stool from a healthy donor to cirrhosis patients who suffer from recurrent hepatic encephalopathy can improve brain functioning, reduce confusion and reduce hospitalization for that patient population. Hepatic encephalopathy is a brain disorder that commonly manifests as a complication of cirrhosis. It can lead to fatigue, inability to concentrate, confusion and, in some cases, death.
Results from the first randomized human trial of the procedure were recently published online in the journal Hepatology.
ÂFecal transplantation has been used to treat other conditions, but this is the first randomized trial of this kind in liver disease and cirrhosis, said Jasmohan S. Bajaj, MD, an associate professor in the School of Medicine. Bajaj led the team of researchers who oversaw fecal microbial transplantation in cirrhosis patients at Hunter Holmes McGuire VA Medical Center. All of the patients in the study were receiving the maximum treatment possible for HE, but continued to suffer from disease–related symptoms.
Bajaj led a study published last year in the journals Hepatology and Scientific Reports that revealed that the gut bacteria found in the intestinal tract and in stool was associated with hepatic encephalopathy. The most recent finding builds upon that research.
ÂThis initial small study shows that even in very sick patients with liver disease, fecal transplants can be safe and can improve brain functioning, Bajaj said. ÂPatients with cirrhosis who are already on maximum treatment could potentially benefit from this research.Â
Bajaj, who practices medicine and teaches at VCU School of MedicineÂs Department of Internal Medicine and at the McGuire VA Medical Center, is already planning next steps. He plans to build on the most recent scientific findings with a new National Institutes of Health–funded research trial that uses oral capsules instead of enemas to achieve the same outcome.
Donor materials for both studies are provided by nonprofit stool bank OpenBiome, which is also a collaborator in the research project.
Go to Original
Results from the first randomized human trial of the procedure were recently published online in the journal Hepatology.
ÂFecal transplantation has been used to treat other conditions, but this is the first randomized trial of this kind in liver disease and cirrhosis, said Jasmohan S. Bajaj, MD, an associate professor in the School of Medicine. Bajaj led the team of researchers who oversaw fecal microbial transplantation in cirrhosis patients at Hunter Holmes McGuire VA Medical Center. All of the patients in the study were receiving the maximum treatment possible for HE, but continued to suffer from disease–related symptoms.
Bajaj led a study published last year in the journals Hepatology and Scientific Reports that revealed that the gut bacteria found in the intestinal tract and in stool was associated with hepatic encephalopathy. The most recent finding builds upon that research.
ÂThis initial small study shows that even in very sick patients with liver disease, fecal transplants can be safe and can improve brain functioning, Bajaj said. ÂPatients with cirrhosis who are already on maximum treatment could potentially benefit from this research.Â
Bajaj, who practices medicine and teaches at VCU School of MedicineÂs Department of Internal Medicine and at the McGuire VA Medical Center, is already planning next steps. He plans to build on the most recent scientific findings with a new National Institutes of Health–funded research trial that uses oral capsules instead of enemas to achieve the same outcome.
Donor materials for both studies are provided by nonprofit stool bank OpenBiome, which is also a collaborator in the research project.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries